Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FC4QB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,676
Award facts
- Contract value 100% obligated
- $13,675.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors with a ceiling value of $13,675.68 under a firm fixed-price contract type. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order represents a non-competitive award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Dupixent is a prescription biologic medication used to treat various inflammatory and immune-mediated conditions, including eczema, asthma, and chronic rhinosinusitis. This delivery order supports the Defense Health Agency and military healthcare systems' pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, regularly fulfills such specialty medication requirements through its comprehensive pharmaceutical prime vendor contract with the DLA, which enables the company to supply medications and medical supplies to support military healthcare programs globally across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FC4QB?
SPE2DB25FC4QB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FC4QB worth?
The government has obligated $13,676 on SPE2DB25FC4QB.
Is contract SPE2DB25FC4QB an order under another contract?
Yes. SPE2DB25FC4QB is a delivery order under SPE2DB20D7066, an indefinite delivery contract.
Was contract SPE2DB25FC4QB competed?
The extent of competition for SPE2DB25FC4QB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award